What’s known?
- COVID-19 rRT-PCR long turnaround time and marginal sensitivity have
led to delays in test results, diagnosis and thus have exposed
non-COVID-19 patients to cross-infection.
- FebriDx, a rapid, point-of-care diagnostic test, that identifies
bacterial, viral infection (or no infection) and may be able to
improve time to diagnosis and cohorting practices.